Phosducin and phosducin-like protein regulate G protein signaling pathways by binding the ␤␥ subunit complex (G␤␥) and blocking G␤␥ association with G␣ subunits, effector enzymes, or membranes. Both proteins are composed of two structurally independent domains, each constituting approximately half of the molecule. We investigated the functional roles of the two domains of phosducin and phosducin-like protein in binding retinal G t ␤␥. Kinetic measurements using surface plasmon resonance showed that: 1) phosducin bound G t ␤␥ with a 2.5-fold greater affinity than phosducin-like protein; 2) phosphorylation of phosducin decreased its affinity by 3-fold, principally as a result of a decrease in k 1 ; and 3) most of the free energy of binding comes from the Nterminal domain with a lesser contribution from the C-terminal domain. In assays measuring the association of G t ␤␥ with G t ␣ and light-activated rhodopsin, both N-terminal domains inhibited binding while neither of the C-terminal domains had any effect. In assays measuring membrane binding of G t ␤␥, both the N-and Cterminal domains inhibited membrane association, but much less effectively than the full-length proteins. This inhibition could only be described by models that included a change in G t ␤␥ to a conformation that did not bind the membrane. These models yielded a free energy change of ؉1.5 ؎ 0.25 kcal/mol for the transition from the G t ␣-binding to the Pd-binding conformation of G t ␤␥.
1
-coupled receptors detect and transduce a wide variety of chemical and physical stimuli in eukaryotic cells. Signals from hormones, neurotransmitters, odorants, and photons use G protein-dependent pathways. These pathways are designed to amplify and integrate a multiplicity of both stimulatory and inhibitory responses. The cellular response is initiated by an agonist-dependent conformational change in the receptor. This starts a cascade of events in which GTP is exchanged for GDP on the ␣ subunit of the heterotrimer G protein (G), and the G protein dissociates into G␣⅐GTP and G␤␥ subunits. Both G␣⅐GTP and G␤␥ then activate effector enzymes or ion channels. These effectors in turn control kinase cascades and second messenger concentrations (cyclic nucleotides, inositol phosphates, lipids, and Ca 2ϩ ) that dictate the cellular response (for recent reviews, see Refs. 1-3).
As a result of their importance in cellular function, G protein signaling pathways are tightly regulated. Much of this regulation occurs at the level of the receptor through phosphorylation, arrestin binding, and receptor internalization (4) . However, evidence is also accumulating for regulation at the level of the G protein. A number of proteins containing RGS (regulators of G protein signaling) domains have been discovered (5) . Binding of an RGS domain to G␣⅐GTP accelerates the rate of GTP hydrolysis, thereby controlling the duration of the G protein signal (6 -10) . In addition, a family of G␤␥-binding proteins, termed phosducins, have been shown to bind G␤␥ subunits and block their function. This family consists of phosducin (Pd), phosducin-like protein (PhLP), and several proposed isoforms of each (11) (12) (13) . Pd is a cytosolic phosphoprotein expressed at very high levels in retinal photoreceptor cells (11, 14) and pinealocytes (15) (16) . Pd binds the photoreceptor-specific isoform of G␤␥ (G t ␤ 1 ␥ 1 ) with high affinity and blocks G t ␤␥ association with both G t ␣ and rod outer-segment disc membranes (17) . When Pd is phosphorylated at Ser-73 by cAMP-dependent protein kinase (PKA) (18) , it no longer blocks association with G t ␣ (17) . The phosphorylation state of Pd is determined by light, being phosphorylated in the dark and dephosphorylated upon illumination (19) . These data have lead to the hypothesis that Pd participates in light adaptation in the following way (20) . In the light, Pd becomes dephosphorylated and binds G t ␤␥. This blocks reassociation of G t ␤␥ with G t ␣⅐GDP, thereby inhibiting further activation of heterotrimeric G t by light-activated rhodopsin (Rho*).
The function of PhLP is less well understood. PhLP is widely expressed at much higher levels than Pd in tissues other than the retina and pineal (12) . It also binds G␤␥ with high affinity (21, 22) . Thus, PhLP may represent a homologue of Pd that regulates a number of G protein pathways in many cell types. Regulation of PhLP activity differs from that of Pd in that PhLP is not a good substrate for PKA, and thus its ability to bind G t ␤␥ is not affected by PKA phosphorylation (23) .
Both Pd and PhLP are composed of two independent domains. The crystal structure of Pd complexed with G t ␤␥ (24) shows that the two domains of Pd wrap around G t ␤␥ forming an extensive interface. Pd buries ϳ2300 Å 2 of solvent-accessible surface area upon binding. The N-terminal domain (Pd-N) accounts for ϳ1500 Å 2 and the C-terminal domain (Pd-C) for ϳ800 Å 2 . Pd-N, which is mostly helical, interacts extensively with the loops on the top of the G t ␤ propeller, the same face of G t ␤␥ that interacts with G t ␣ and other G␤␥-dependent effec-tors (25) . Pd-C shows structural homology to thioredoxin and binds the outer strands of the G t ␤-propeller blades 1 and 7 (numbered as in Ref. 26 ) at the putative membrane-binding site of G t ␤␥ and has been proposed to sterically block binding of G t ␤␥ to the membrane (24) .
The crystal structure of the complex also showed a local change in the conformation of G t ␤␥ in three loops (287-295, 308 -318, and 329 -338) compared with the structure of free or G t ␣-bound G t ␤␥ (24) . These loops interact with residues in the far N-terminal loop, helix 3, and the C-terminal domain of Pd. It has been postulated that the pocket created by this conformational change harbors the C-terminal farnesyl group of G␥ that helps anchor free G t ␤␥ in the membrane (27) . Burying the hydrophobic farnesyl moiety in this manner may contribute to the dissociation of G t ␤␥ from the membrane that occurs upon Pd binding (11, 17) .
The fact that Pd-N accounts for ϳ65% of the contact surface is consistent with previous reports showing that the G␤␥ binding domain is localized to this domain (28 -31) . These studies have also shown that a stretch of 11 residues in Pd-N, perfectly conserved between Pd and PhLP, is essential for G␤␥ binding and translocation from the membrane. These conserved residues form helix 1 of Pd, of which 7 of the 11 residues make contacts with G␤␥ (24) . In contrast, other work has reported that a small fragment from Pd-C (residues 215-232) is sufficient for disrupting G␤␥ interactions with G o ␣ and effectors (32) . Moreover, a short form of PhLP (residues 84 -301; Ref. 12), which lacks helix 1 (residues 57-67 of PhLP), was reported to block G␤␥ functions (21) . Furthermore, studies measuring binding of truncated PhLP fusion proteins to G␤␥ have demonstrated independent binding of G␤␥ to both the N-and Cterminal halves of PhLP (22) .
Because of this uncertainty concerning the relative functions of the N-and C-terminal domains in blocking membrane and G t ␣ binding of G t ␤␥, we have systematically analyzed the roles of the two domains of Pd and PhLP using functional assays of receptor and membrane binding. In addition, we have measured the kinetics of binding of the two domains using surface plasmon resonance (SPR) techniques. We also examine the effect of the G t ␤␥ conformational change that occurs upon Pd binding on membrane association and estimate the free energy of the conformational change. From the data, we propose a model for the function of the two domains in the inhibition of G t ␣ binding to G t ␤␥ and the dissociation of G t ␤␥ from the membrane.
EXPERIMENTAL PROCEDURES
Preparation of Domain Constructs-The pET 15b vector (Novagen, Madison, WI) containing the recombinant rat Pd cDNA with a His 6 tag as well as the pET 11a vectors containing the amino-terminal (Pd-N, residues 12-107) and carboxyl-terminal (Pd-C, residues 108 -246) domains of rat Pd (33) were a gift from Dr. R. Gaudet (Harvard University). The gene encoding PhLP was cloned by reverse transcription/PCR from rat kidney total mRNA using RNasin/avian myeloblastosis virus reverse transcriptase (Promega, Madison, WI), followed by PCR amplification using the forward primer 5Ј-cgcggcagccatatgacaaccctggatgac-3Ј, containing an NdeI restriction site, and the reverse primer 5Ј-agccggatccttatcaatctatttctagatcgc-3Ј, containing a BamHI restriction site and Taq DNA polymerase (Life Technologies, Inc.). The cDNA was then subcloned into the pET 15b vector using NdeI and BamHI, and transformed into BL-21(DE3) cells (Life Technologies, Inc.) for protein expression.
The N-terminal domain of rat PhLP (PhLP-N, residues 1-153) was constructed by PCR using the above construct as template, with the forward primer 5Ј-cgcggcagccatatgacaaccctggatgac-3Ј, containing an NdeI restriction site, and the reverse primer 5Ј-agccggatccttaatgaagctgctgccgcatc-3Ј, containing a BamHI restriction site and Taq DNA polymerase (Life Technologies, Inc.). The amplicon was subcloned into the pET 15b vector using NdeI and BamHI, and transformed into BL-21(DE3) cells for protein expression.
The C-terminal domain of rat PhLP (PhLP-C, residues 153-301) was constructed by PCR using the full-length construct as template, with the forward primer 5Ј-cgcggcagccatatgcataaagggccccaattc-3Ј, containing an NdeI restriction site, the reverse primer 5Ј-agccggatccttatcaatctatttctagatcgc-3Ј, containing a BamHI restriction site and Taq DNA polymerase (Life Technologies, Inc.). The amplicon was subcloned into the pET 15b vector using NdeI and BamHI, and transformed into BL-21(DE3) cells for protein expression. All constructs were sequenced to verify the correct nucleotide composition.
Purification of Pd Domains, G t ␣, G t ␤␥, and Preparation of UROSPreparation of bovine urea-stripped rod outer segment (UROS) membranes, G t ␣, and G t ␤␥, as well as 125 I-labeling of the G protein subunits, was performed as described previously (17) . His 6 -tagged Pd, Pd-N, Pd-C, PhLP, PhLP-N, and PhLP-C were expressed in Escherichia coli and purified on a nickel-chelate column. A single E. coli colony was grown in 1 liter of Luria-Bertani media with 50 g/ml ampicillin at 37°C until the optical density was between 0.8 and 1.0 (ϳ20 h). Expression was induced by adding 500 M isopropyl-␤-D-thiogalactopyranoside and incubating for another 3 h at 37°C. Cells were pelleted by centrifuging at 4,000 ϫ g for 10 min. The supernatant was discarded, and the pellet was resuspended in 10 ml of B-PER cell lysis reagent (Pierce) containing 1 mM phenylmethylsulfonyl fluoride. The cell suspension in B-PER was sonicated on ice with three 20-s pulses from a tip sonicator with 2-min pauses between pulses to avoid overheating the sample. The sonicated samples were centrifuged at 150,000 ϫ g for 20 min. The supernatant was removed and loaded on a Probond nickel chelate column (Invitrogen, Carlsbad, CA) with an ϳ10-ml bed volume equilibrated in Equilibration buffer (20 mM Tris-HCl, pH 8.0, 500 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, and 50 mM imidazole). The column was washed with Equilibration buffer until the non-bound proteins had eluted. The His 6 -tagged Pd was eluted with Equilibration buffer at pH 7.0 containing 300 mM imidazole. The Pd was concentrated and buffer-exchanged by ultrafiltration into isotonic buffer (20 mM HEPES, pH 7.5, 100 mM NaCl, 20 mM KCl, 5 mM MgCl 2 , 1 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride) for binding assays. The Pd and PhLP species purified in this manner were Ͼ95% pure as determined by Coomassie Blue-stained SDS-PAGE gels.
Kinetics Analysis of Pd Domain Binding to G t ␤␥-The binding kinetics of Pd, PhLP, and their N-and C-terminal domains were measured by optical detection of SPR (34 -35) using a BIACORE 2000 instrument (BIACORE AB, Uppsala, Sweden). Each His 6 -tagged full-length protein or individual domain was immobilized on a single flow cell surface of a Ni 2ϩ -NTA chip. Molar equivalent amounts of protein were immobilized, ranging from 150 response units (RU) for the 36-kDa full-length PhLP to 50 RU for the 12 kDa Pd-N. To measure the binding kinetics, purified G t ␤␥ in Eluent buffer (10 mM HEPES, 150 mM NaCl, 0.05 mM EDTA, 0.005% surfactant P20, pH 7.4) at five known concentrations (ϳ5-fold above and below the K d ) was injected at 20 l/min over the test flow cell surface containing the immobilized Pd and over a control flow cell surface without immobilized protein. The 5-min binding phase was followed by a similar 5-min dissociation phase in which Eluent buffer without G t ␤␥ was passed over both surfaces. The response from the control flow cell was subtracted from the test flow cell using the BIA-CORE BIAevaluation software to remove components of the response resulting from nonspecific binding of G t ␤␥ to the Ni 2ϩ -NTA surface or from differences in refractive index between the G t ␤␥-containing Eluent buffer and Eluent buffer alone. Nonspecific binding was minimal at nanomolar concentrations of G t ␤␥, but became more significant at micromolar concentrations. By 10 M G t ␤␥, nonspecific binding accounted for ϳ50% of the response and thus, binding affinities higher than 10 M could not be analyzed accurately. Between each run, both flow cells were regenerated with 20 l of Eluent buffer containing 350 mM EDTA and then recharged with 20 l of 500 M NiCl 2 in Eluent buffer.
A set of curves was generated for each Pd species from the background-subtracted curves at each of the five G t ␤␥ concentrations tested. This set of five curves was simultaneously fit to a simple one-to-one bimolecular binding model with base-line drift by a global analysis using the BIAevaluation software. From the global fit, the association and dissociation rate constants (k 1 and k Ϫ1 , respectively), and the equilibrium dissociation constant (K d ) were obtained. Chi-square values of the fits ranged from 0.62 to 4.6. The data were also fit to a model that requires a conformational change in G t ␤␥ for binding to occur (see Fig. 4 ) using the Clamp SPR analysis software (35) . There was no difference in the fit of the two models because the rates of the conformational change were much faster than the rates of Pd binding to G t ␤␥.
The K d values were also measured from the steady state RU values and were very similar to the K d values obtained from the k Ϫ1 /k 1 ratio. Base-line drift is commonly encountered with Ni 2ϩ -NTA surfaces re-sulting from loss of the His 6 -tagged protein during the run. This drift did not exceed ϳ2 RU lost/min. For phosphorylated Pd, 10 M Pd was phosphorylated with 0.5 unit/l of purified PKA catalytic subunit (Fluka, Ronkonkoma, NY) in 50 l of phosphorylation buffer (20 mM HEPES, pH 7.4, 150 mM NaCl, 2.0 mM MgCl 2 , 1.0 mM ATP, 1.0 mM dithiothreitol, 50 M EDTA) for 10 min at 23°C prior to immobilization. This results in quantitative phosphorylation of Pd at serine 73 (17) (18) . The phosphorylated Pd was diluted to 50 nM in Eluent buffer and immobilized on the Ni 2ϩ -NTA surface. With recombinant Pd purified from E. coli, the phosphorylated form is very stable (33) . Thus, the phosphorylation state was maintained after immobilization during the ϳ15-min course of a G t ␤␥ injection.
Functional Assays of Pd Domain Binding to G t ␤␥-Binding of 125 I-G t ␣ to light-activated rhodopsin (Rho*) in the presence of G t ␤␥ was measured as described previously (17) with modifications. Briefly, 0.2 M 125 I-G t ␣ and 0.2 M G t ␤␥ were incubated with UROS membranes at 1.0 M rhodopsin in the dark with increasing concentrations of Pd, PhLP, or their N-and C-terminal domains. Light-induced binding was initiated by illuminating for 1 min, producing a 50% bleach of the rhodopsin. In the absence of guanine nucleotides, the Rho*G t formed upon bleaching is stable for several hours (36) . Samples were centrifuged at 40,000 ϫ g for 20 min, and the amount of 125 I-G t ␣ in the pellet was quantified. Nonspecific binding was determined in samples without G t ␤␥ and was subtracted from all samples. The light-induced binding data were plotted and fit by non-linear least squares regression using the Kaleidagraph graphics program (Synergy Software, Reading, PA) to the following inhibition equation:
n ), where IC 50 is the half-maximal inhibition and n is the Hill coefficient.
Binding of 125 I-G t ␤␥ (0.36 M) to unilluminated UROS membranes (10 M Rho) was measured at the indicated Pd, PhLP, and their N-and C-terminal domain concentrations as described previously (17) . The data were plotted and fit using Kaleidagraph to equations derived from two different models of Pd inhibition of membrane binding. The fulllength proteins and C-terminal domains were fit to Model 1 (Fig. 4) . From the expressions for the equilibrium constants in this model, the expressions for the conservation of mass, and the expression for the conservation of energy (i.e. (2) ), an expression for membrane-bound G t ␤␥ was obtained in the form of a quadratic equation.
A[M⅐G t ␤␥]
2 ϩ B͓M⅐G t ␤␥]ϩC ϭ 0, where: (Eq. 1) The N-terminal domain inhibition data were fit to Model 2 (Fig. 4) . A quadratic expression for the membrane-bound G t ␤␥ was obtained as described for Model 1, except that there were two membrane-bound species in Model 2, G t ␤␥⅐M and Pd-N⅐G t ␤␥⅐M. The quadratic terms for [G t ␤␥⅐M] were as follows.
The quadratic terms for [Pd-N⅐G t ␤␥⅐M] were as follows.
The total membrane-bound G t ␤␥ was calculated as the sum of Equations 2 and 3.
In the case in which
, Models 1 and 2 reduce to Model 3. The quadratic terms for the equation describing this model were as follows.
A ϭ Ϫ1;
(Eq. 4)
RESULTS

Kinetics Analysis of Pd Domain
Binding to G t ␤␥-In order to quantify the binding of Pd domains to G t ␤␥, their interactions were measured by SPR techniques (34) using a BIACORE 2000 instrument. Pd domains were immobilized on a Ni 2ϩ -NTA chip, and G t ␤␥ was applied to the binding surface. The kinetics of both association and dissociation events were measured at five different G t ␤␥ concentrations above and below the K d for each Pd and PhLP species. From these data, families of curves were generated and fit by global analysis using the BIAevaluation software (BIACORE). Global analysis simultaneously fits k 1 , k Ϫ1 , and the surface binding capacity at each G t ␤␥ concentration. An example of the fitted data for full-length Pd is shown in Fig. 1A . Two to four similar data sets were collected for each full-length protein or N-terminal domain as well as for phosphorylated Pd using two or three different G t ␤␥ preparations. There was good agreement between data sets. The binding parameters resulting from this analysis are summarized in Table I . K d values were determined from the k Ϫ1 /k 1 ratio as well as from the steady-state binding levels reached during the association phase (Fig. 1B) , respectively, with a corresponding K d of 42 Ϯ 6 nM (n ϭ 3). From steady-state measurements, the K d was 47 Ϯ 0.3 (n ϭ 3). Both the full-length proteins and the N-terminal domains showed similar agreement between these two methods of measuring K d values.
PhLP bound G t ␤␥ with slightly lower affinity than Pd with a K d of 107 nM. Most of the affinity decrease resulted from a 2-fold decrease in k 1 . The N-terminal domains bound with significantly lower affinity than the full-length domains, with K d values of 4800 and 494 nM for Pd-N and PhLP-N, respectively. Interestingly, all of the decrease in binding affinity for Pd-N compared with PhLP-N was a result of a 10-fold decrease in k 1 for Pd-N. Phosphorylation of Pd by PKA resulted in a 3-fold decrease in binding affinity. Most of this decrease was a result of a 2-fold decrease in k 1 . Modest differences in G t ␤␥ binding affinity between the two phosphorylation states of Pd is consistent with previous data (17, 38) . Binding of the Cterminal domains to G t ␤␥ was also measured by SPR using the Ni 2ϩ -NTA chip. However, no observable binding was measured up to 10 M G t ␤␥ (data not shown). Above this concentration, nonspecific binding of G t ␤␥ to the chip became prohibitively high. Thus, the K d values for the C-terminal domains must be significantly greater than 10 M.
Pd Domain Inhibition of G t Binding to Rho*-High affinity binding of G t ␣ to Rho* requires G t ␤␥ (39 -41), while Pd binding to G t ␤␥ sterically interferes with G t ␣ binding to G t ␤␥ (17, 24) . Thus, Pd blocks the association of G t ␣␤␥ with Rho* by inhibiting heterotrimer formation (17) . To determine which domain of Pd and PhLP is responsible for inhibition of G t ␣⅐G t ␤␥ interactions, we measured the ability of Pd, PhLP, and their individual domains to block the binding of 125 I-G t ␣ and G t ␤␥ to Rho* in UROS membranes (Fig. 2) . Both full-length Pd and PhLP potently inhibited binding to Rho* with half-maximal inhibition (IC50) occurring at 0.15 and 0.29 M, respectively ( Fig. 2A) . Phosphorylation of Pd by PKA increased its IC 50 by 17-fold to 2.6 M, as observed previously (33) . Pd-N and PhLP-N also inhibited binding to Rho*, but less effectively than their full-length counterparts (Fig. 2B) . IC 50 values were 2.5 M for Pd-N, 6.8 M for PhLP-N, and 14 M for P-Pd-N. IC 50 values are summarized in Table II . Surprisingly, Pd-N was a better inhibitor of G t ␣ binding to G t ␤␥ than PhLP-N despite the fact that Pd-N has an approximately 10-fold lower binding affinity for G t ␤␥ than PhLP-N. Possible reasons for this difference are discussed below (see "Discussion"). PhLP is a much poorer substrate for PKA, and stochiometric phosphorylation could not be accomplished (23) ; therefore, phosphorylated PhLP or PhLP-N was not tested. In contrast to the results with the N-terminal domains, Pd-C and PhLP-C had essentially no effect on G t binding to Rho* (Fig. 2C) . By 250 M, only ϳ20% inhibition had occurred. Thus, it is the N-terminal domain and 
Error bars represent the standard deviation of the data from three experiments. The average maximal equilibrium RU value from the three experiments was 117 Ϯ 27 RU with 134 Ϯ 12 RU of immobilized Pd.
TABLE I
Summary of kinetic data for Pd domain binding to G t ␤␥ Association and dissociation rate constants for the interaction of the full-length proteins or the N-terminal domains with G t ␤␥ were obtained from global fit analysis of data similar to Fig. 1A . Dissociation constants (K d ) were calculated from the k Ϫ1 /k 1 ratio. Two to four separate data sets were analyzed for each Pd species from two or three different G t ␤␥ preparations. Average values are reported Ϯ standard deviation. Kinetic parameters for the C-terminal domains were not determined (ND) because their binding affinity was prohibitively low (see text). *, K d values for the C-terminal domains were obtained from the equilibrium analysis of their inhibition of G t ␤␥ binding to UROS membranes (Fig. 3C) .
Pd (n ϭ 3) 1.10 Ϯ 0.25 ϫ 10 
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not the C-terminal domain that is responsible for blocking the binding of G t ␣ to G t ␤␥ and inhibiting binding of G t ␣␤␥ to Rho*. The fact that the full-length proteins inhibit binding at significantly lower concentrations than the N-terminal domains suggests that the C-terminal domain does add to the binding affinity of the full-length proteins.
The K d for the Pd⅐G t ␤␥ interaction is lower than the IC 50 values reported in Fig. 2 Fig. 1 ), which avoided problems associated with obtaining the K d values from IC 50 measurements in this assay.
Pd Domain Inhibition of G t ␤␥ Binding to UROS Membranes-It has been postulated that the role of Pd-C is to block membrane association of G t ␤␥ (24). To test this possibility, the effect of Pd and PhLP domains on the binding of
125 I-G t ␤␥ to UROS membranes was measured (Fig. 3) . Full-length Pd and PhLP both inhibited membrane binding effectively (Fig. 3A) . IC 50 values were near 0.7 M for both (Table III) . Unexpectedly, the N-terminal domains also inhibited membrane binding (Fig.  3B) . However, they were ϳ100-fold less effective than the fulllength proteins. The ϳ70 M IC 50 values (Table III) (Table  I) . Therefore, other factors must be involved. The structure of the Pd⅐G t ␤␥ complex shows no interaction of Pd-N with the region of G t ␤␥ that is involved in membrane binding. As a result, Pd-N must block membrane binding allosterically. A possible source of this allosterism is the conformational change that occurs in G t ␤␥ upon binding Pd (24, 27) . If Pd-N also induces the conformational change in G t ␤␥ like full-length Pd, creating a pocket in which the farnesyl group of G␥ is buried and not available for membrane association, then it could inhibit membrane binding of G t ␤␥. In order to test this possibility, the membrane inhibition data for the full-length proteins and the domains were fit to possible models for membrane inhibition that include such a conformational change (Fig. 4) . In Model 1, the full-length proteins or C-terminal domains bind either conformation of G t ␤␥. They potentially block binding of G t ␤␥ to the membrane by both steric inhibition from the Cterminal domain and by inducing the G t ␤␥* conformation (the conformation found in the Pd⅐G t ␤␥ structure) that does not bind the membrane. In Model 2, Pd-N binds to both conformations of G t ␤␥ but does not inhibit membrane binding until G t ␤␥* is formed. The K d values for Pd-N binding G t ␤␥ (the membrane-binding conformation) are taken to be equal whether G t ␤␥ is membrane-bound or not, since there is no structural evidence for steric hindrance of the membrane binding site by Pd-N. Both Models 1 and 2 reduce to Model 3 if binding to G t ␤␥* is much greater than binding to
The membrane inhibition data of Fig. 3 were fit to equations 
TABLE II Summary of IC 50 values for Pd domain inhibition of G t binding to
Rho* IC 50 values were obtained from fits of the data as described in Fig. 2 . Error values are from the fits of the combined data from the number of experiments indicated (n). P-Pd, phosphorylated Pd; P-Pd-N, phosphorylated Pd-N. 
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derived from these models in order to obtain estimates of K c (1) and K d(3) (see "Experimental Procedures"). K d (2) values were fixed to those obtained by BIACORE analysis ( 
) added approximately 10% error in the values for K c (1) and K d (3) . Having values for the other constants permitted the calculation of K c (2) . It follows from Model 1 that
, yielding a value of 0.72 Ϯ 0.28 for K c (2) . Table IV 4 . Models of Pd and PhLP inhibition of G t ␤␥ binding to UROS membranes. Three potential models describing the competition between Pd and membrane sites for binding to G t ␤␥ are depicted. See "Results" for a detailed description of the models. G t ␤␥* represents the conformation in which the farnesyl group of G t ␥ is buried in a groove of G t ␤ and has little to no affinity for the membrane. M represents the membrane binding sites of G t ␤␥.
contains a summary of the final values for the equilibrium constants.
A similar analysis of the equilibrium constants can be done for the N-terminal domains by applying Equations 2 and 3 from Model 2 to the membrane inhibition data of The C-terminal domains were also weak inhibitors of membrane binding with IC50 values at ϳ100 M (Fig. 3C) . To fit the data to Model 1, K d (2) values for the C-terminal domains are necessary. However, the binding of the C-terminal domains to G t ␤␥ was low and K d (2) could not be determined by SPR. No binding was observed at 10 M G t ␤␥, the highest concentration that could be tested without excessive interference from nonspecific binding (data not shown). However, it was clear from the SPR measurements that K d(2) must be significantly higher than 10 M. Therefore, the data were fit to Equation 1 from Model 1 with K d (2) fixed at 10 M or greater. The resulting K c (1) values were approximately 0.05 and 0.04, and K d (3) values were approximately 60 M and 50 M for Pd-C and PhLP-C, respectively, and were independent of the exact K d (2) value. This is because, when K d (2) is greater than 10 M, Pd-C inhibits membrane binding through binding to G t ␤␥ and not G t ␤␥* (see Model 1, Fig. 4 ). The requirement for K d (2) values to be significantly greater that 10 M and the fact that the resulting K d (3) values fall between 50 and 60 M strongly suggest that the C-terminal domains bind G t ␤␥ and G t ␤␥* with similar affinity.
values of 64 Ϯ 6 M and 41 Ϯ 9 M are obtained for Pd-C and PhLP-C, respectively. Even with this constraint, K c(1) values had significant uncertainty, being 0.051 Ϯ 0.061 for Pd-C and 0.04 Ϯ 0.14 for PhLP-C. However, these values are in reasonable agreement with those obtained for Pd, PhLP, and Pd-N. From this analysis, it appears that the C-terminal domains bind G t ␤␥ with ϳ50 M affinity and do not distinguish between the two conformations of G t ␤␥.
Previous work has suggested that Pd-N and Pd-C function independently in solution and in binding G t ␤␥ (24, 33) . To further test the functional independence of the two domains, inhibition of G t ␤␥ binding to UROS membranes was measured in the presence of both domains. In the case of Pd, combining the domains caused a moderate increase in inhibition of G t ␤␥ binding compared with the individual domains (Fig. 5A) . The IC 50 for the combined domains was 27 M compared with 81 M for Pd-N alone and 103 M for Pd-C alone (Table III) . This increase in inhibition is what would be predicted if the N-and C-terminal domains bound G t ␤␥ simultaneously and independently. The solid line in Fig. 5 represents the predicted inhibition curve for simultaneous, independent binding of the two domains. The theoretical curve was generated by using the equilibrium constants obtained from Model 3 for Pd-N and Model 1 for Pd-C (Table IV) Fig. 4 . See text for description of the models and equations. *, these values are from the SPR kinetic analysis summarized in Table I . PhLP-C 0.04 Ϯ 0.14 ϭ K c (1) 41,000 Ϯ 9,000 ϭ K d (2) domains do indeed bind independently. In order for this observation to be true, binding of Pd-C must be insensitive to the conformational change that occurs in G t ␤␥ upon Pd-N binding. This fact supports the prediction from the analysis of Pd-C inhibition data (Fig. 3C) 
for Pd-C in Model 1 (Fig.  4) . Another observation from Fig. 5A is that inhibition by the combined domains does not approach the efficacy of full-length Pd. This is as expected because of the greatly reduced affinity of the individual domains compared with that of full-length Pd and the lack of synergy in their binding of G t ␤␥. Moreover, entropic factors favor the dissociation of the trimeric Pd-N⅐G t ␤␥⅐Pd-C complex over the dissociation of the dimeric Pd⅐G t ␤␥ complex. In the case of PhLP, combining the domains caused no significant change in the inhibition of G t ␤␥ binding to membranes (Fig. 5B) . The IC 50 value for the combined domains was 55 M, compared with 68 M for PhLP-N and 66 M for PhLP-C alone (Table III) . If the domains were binding independently, then increased inhibition would be predicted, as depicted by the solid line in Fig. 5B . This result indicates that simultaneous binding of PhLP-N and PhLP-C to G t ␤␥ is hindered. This hindrance could be the reason why the binding affinities of individual PhLP domains for G t ␤␥ are higher than those of Pd domains, yet the binding affinity of full-length PhLP is less than fulllength Pd. Potential sources of the hindrance are steric overlap of the binding sites or allosteric competition through the conformational change. Whatever the source, it is clear that PhLP domains bind G t ␤␥ in significantly different ways than Pd.
DISCUSSION
From the data presented, a model describing the separate functions of the two domains of Pd and PhLP can be proposed (Fig. 6) . The N-terminal domain sterically blocks association of G t ␣ with G t ␤␥ and thereby inhibits binding to light-activated Rho*. This is consistent with the crystal structure of the Pd⅐G t ␤␥ complex (24) , which shows considerable overlap in binding surfaces between Pd-N and G t ␣ on G t ␤␥. The N-terminal domain interacts almost exclusively with the G t ␤␥* conformation that buries the G t ␥ farnesyl group in a groove of G t ␤ created by the conformation change. Thus, this domain appears to inhibit membrane binding by stabilizing a conformation that does not have the farnesyl group available for insertion into the membrane. The C-terminal domain does not interfere with G t ␤␥ binding to G t ␣, yet it does inhibit G t ␤␥ binding to the membrane (Fig. 3C) . This result supports the structural prediction that the Pd-C binding surface along G t ␤ propeller blades 1 and 7 where the farnesylated G t ␥ C terminus is located (24, 27) is also the membrane association site of G t ␤␥. The C-terminal domain appears to bind the two conformations of G t ␤␥ with similar affinity. Both the N-and C-terminal domains contribute to the high affinity interaction with G t ␤␥, with the N-terminal domain contributing more binding energy than the C-terminal domain. Using ⌬G ϭ ϪRTlnK, ⌬G for the dissociation of the complex can be determined for each domain, yielding values of 7.2 and 5.7 kcal/mol at room temperature (23°C) for Pd-N and Pd-C, respectively. If the domains act independently to bind G t ␤␥ as has been suggested (33), then the ⌬G values for full-length Pd would be additive, yielding a ⌬G of 12.9 kcal/mol and a corresponding K d of 0.3 nM. This value is 100-fold less than the measured K d (2) for Pd of 42 nM. The difference may be explained by a loss of energy caused by geometric constraints that limit the contacts that can be simultaneously made by each domain with G t ␤␥ when they are tethered together in the same polypeptide. Thus, the data suggest that the individual domains bind somewhat differently than the intact protein.
An accurate description of the membrane inhibition data for the full-length proteins and N-terminal domains required inclusion of a G t ␤␥* conformation with little or no membrane affinity. This result supports the observation of Loew et al. (27) that the farnesyl group of G t ␥ may be buried in the shallow groove between G t ␤␥ propeller blades 1 and 7 (blades 6 and 7 following the numbering of Loew et al.) that is observed only in the Pd⅐G t ␤␥ structure and not in the free G t ␤␥ or the G t ␣␤␥ structures. From fits of the data to such models, values of the equilibrium constant for this conformational change were obtained. Since the conformational change should be independent of the Pd species it binds, the best estimate of K c (1) was obtained by averaging the K c (1) values from each Pd species. This yielded a K c(1) value of 0.074 Ϯ 0.023. From ⌬G c(1) ϭ ϪRTlnK c (1) , the estimated free energy of the conformational change was calculated to be ϩ1.5 Ϯ 0.25 kcal/mol at 23°C. This small increase in the free energy of G t ␤␥ appears commensurate with the modest change in its structure when complexed to Pd. It should be noted that the K c (1) for PhLP-N was excluded from this average because it was approximately 10-fold less than the other K c (1) values. We have no reason to suspect that this difference is caused by experimental errors that were not a part of the other five membrane inhibition experiments. Three different PhLP-N preparations and two different G t ␤␥ prepa- (23) is shown oriented with the membrane binding face of G t ␤␥ against the membrane (G␤, red; G␥, gray). Pd-C (dark blue) binds to this same face and sterically interferes with membrane association. G t ␣⅐GDP (green) is oriented on the membrane with respect to G t ␤␥ as it would be in the G t heterotrimer (43) . Pd-N (light blue) occupies the face of G t ␤␥ that interacts with G t ␣⅐GDP and thus interferes with formation of the G t heterotrimer.
rations were used to generate the five sets of PhLP-N data. Therefore, it is unlikely that artifacts from a particular protein preparation are responsible. We are left to conclude that PhLP-N may bind to a conformation of G t ␤␥ not found with the other Pd species. This may be why PhLP-N appears to be a poorer inhibitor than Pd of interactions of G t ␤␥ with G t ␣ (Fig.  2B) . Unlike PhLP-N, full-length PhLP appears to induce a similar G t ␤␥* conformation as Pd. This difference between PhLP-N and PhLP could be that the full-length protein is conformationally constrained by the C-terminal domain to induce only the G t ␤␥* conformation.
Both the k 1 and k Ϫ1 values for Pd (Table I) were significantly higher than those reported previously from SPR measurements (13, 29) . The most likely explanation for the difference is in the method of immobilization. We immobilized Pd via an N-terminal His 6 tag. Previous studies immobilized biotinylated G t ␤␥ at undetermined sites. If immobilization hinders access to the binding site, then measured k 1 values will be less than the actual k 1 . Immobilization via the His 6 tag at the N terminus of Pd does not interfere with the Pd⅐G t ␤␥ interaction because the N-terminal tag is not involved in the binding (24) . Moreover, removal of the His 6 tag by proteolysis did not change the IC 50 values for inhibition of G t binding to Rho* (data not shown). Thus, we expect that the accuracy of the rate constants reported here will reflect this improvement in experimental conditions.
The kinetic measurements showed that Pd phosphorylation by PKA decreased the K d for binding to G t ␤␥ by 3-fold. This result confirms previous reports of modest decreases in G t ␤␥ binding affinity when Pd was phosphorylated (17, 38) . Most of the decrease in K d came from a 2-fold decrease in k 1 (Table I) . Phosphorylation at Ser-73 has been proposed to destabilize helix 2 of Pd by disrupting its N-terminal helix cap (33) . Further destabilization of the Pd structure by phosphorylation could cause the observed increase in the k 1 by increasing the conformational space to search before a binding conformation is adopted. The 1.5-fold increase in k Ϫ1 upon phosphorylation indicates that some contacts have been lost in the Pd⅐G t ␤␥ complex. This result is consistent with the crystal structure of the phosphorylated Pd⅐G t ␤␥ complex which showed a loss of ϳ350 Å 2 of binding surface resulting from destabilization of helix 2 (33) .
The binding constant for Pd was 42 nM compared with 107 nM for PhLP (Table I ). This suggests some specificity between Pd and PhLP in binding G t ␤␥ (G␤ 1 ␥ 1 ), the retinal isoform of G␤␥. Pd and G␤ 1 ␥ 1 are physiologically significant binding partners. Both are found together in abundance in retinal rods. We have recently shown PhLP expression in rods but at much lower levels than Pd (23) . Given the greater abundance of Pd in these cells and the lower binding affinity of PhLP for G t ␤␥, it is doubtful that PhLP binds G t ␤␥ in rods. PhLP is found at much higher expression levels in retinal bipolar cells, where Pd is absent (23) . Moreover, it is expressed in many tissues where Pd levels are low or nonexistent (12, 16, 42) . Whether PhLP binds the G␤␥ isoforms expressed in these other cell types with higher affinity than Pd or whether PhLP and Pd are segregated to different cell types are open questions.
In summary, most of the available data support a model in which the N-terminal domains of Pd and PhLP bind G t ␤␥ on the same surface as G t ␣ and thus compete with G t ␣ for G t ␤␥ binding. Interactions with the N-terminal domain contribute to a conformational change in G t ␤␥ that tucks its farnesyl group into a protein pocket, thereby decreasing the affinity of G t ␤␥ for the membrane. Most of the binding energy of the complex is derived from the N-terminal domain. The C-terminal domain binds G t ␤␥ with much lower affinity. Nevertheless, this interaction is important because it occurs at the membrane association surface of G t ␤␥ and blocks membrane binding. The Cterminal domain appears to have no effect on the association of G t ␣ with G t ␤␥. When the two domains are tethered together in the same polypeptide, the full-length protein effectively sequesters G t ␤␥ by blocking both G t ␣ and membrane binding in a high affinity Pd⅐G t ␤␥ complex.
